|
FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic
|
11 May 2021 |
|
FDA and CDC lift recommended pause on Johnson & Johnson (Janssen) COVID-19 vaccine use following thorough safety review
|
23 April 2021 |
|
FDA revokes emergency use authorization for monoclonal antibody Bamlanivimab
|
16 April 2021 |
|
Joint CDC and FDA statement on Johnson & Johnson COVID-19 vaccine
|
13 April 2021 |
|
FDA issues Emergency Use Authorization for third COVID-19 vaccine
|
27 February 2021 |
|
FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
|
09 February 2021 |
|
FDA takes additional action in fight against COVID-19 by issuing Emergency Use Authorization for second COVID-19 vaccine
|
18 December 2020 |
|
FDA takes key action in fight against COVID-19 by issuing Emergency Use Authorization for first COVID-19 vaccine
|
12 December 2020 |
|
FDA authorizes monoclonal antibodies for treatment of COVID-19
|
21 November 2020 |
|
FDA approves first treatment for COVID-19
|
23 October 2020 |
|
FDA issues emergency use authorization for convalescent plasma as potential promising COVID-19 treatment
|
23 August 2020 |
|
FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines
|
30 June 2020 |
|
FDA announces first of its kind pilot program to communicate patient reported outcomes from cancer clinical trials
|
24 June 2020 |
|
FDA revokes emergency use authorization for chloroquine and hydroxychloroquine
|
15 June 2020 |
|
FDA takes new actions to accelerate development of novel prevention, treatment options for COVID-19
|
12 May 2020 |
|
FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment
|
01 May 2020 |
|
FDA reiterates importance of close patient supervision for 'off-label' use of antimalarial drugs
|
24 April 2020 |
|
FDA encourages recovered patients to donate plasma for development of blood-related therapies
|
16 April 2020 |
|
FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19
|
03 April 2020 |
|
FDA Continues to Accelerate Development of Novel Therapies for COVID-19
|
01 April 2020 |